The HER2 Factor: How It Affects TNBC Patients on Capecitabine
Triple-negative breast cancer (TNBC) is a tough nut to crack. When patients receive adjuvant capecitabine, doctors aren't quite sure how the HER2 protein will impact their survival. Let's dive into this puzzle. First, what's HER2? It's a protein that can sometimes go into overdrive in breast cancer